NECTIN1 and brain neoplasm: Friedman et al. demonstrated in pediatric brain tumors that the sensitivity of tumors to M002 correlated with CD111 expression up to a certain level, but as noted in previous publications, the baseline expression of CD111 was a biomarker for M002 success [20,24].